Possible link between statin and iron deficiency anemia: A South Korean nationwide population-based cohort study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 37889968.
- Also identified by DOI 10.1126/sciadv.adg6194 and PMC identifier 10610901.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An extensive evaluation of disease occurrence after statin use based on a "hypothesis-free" approach remains scarce. To examine the effect of statin use on the potential risk of developing diseases, a propensity score-matched cohort study was executed using data from the National Sample Cohort in South Korea. A total of 7847 statin users and 39,235 nonstatin users were included in the final analysis. The period of statin use was defined as our main time-dependent exposure and was divided into three periods: current, recent, and past. The main outcomes were defined as new-onset diseases with ≥100 events based on the International Statistical Classification of Diseases, 10th Revision. We calculated the adjusted hazard ratios and 95% confidence intervals (CIs) using Cox regression. We found that statin use significantly increased the risk of developing iron deficiency anemia up to 5.04 times (95% CI, 2.11 to 12.03). Therefore, the iron levels of patients using statins should be monitored carefully.
Medical subject headings
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Anemia, Iron-Deficiency